The current P/E ratio for West Pharmaceutical Services stock as of Nov 21, 2024 is 47.12. This is calculated based on the TTM EPS of $6.81 and the stock price of $320.88 per share. The current PE ratio is about the same compared to the last 4 quarters average.
The average historical PE ratio of West Pharmaceutical Services for the last ten years is 45.03. The current price-to-earnings ratio of 47.12 is 4.6% more than the historical average. Analyzing the last ten years, WST's PE ratio reached its highest point in the Sep 2020 quarter at 64.99, when the price was $274.9 and the EPS was $4.23. The lowest point was recorded in the Sep 2022 quarter, when it reached 29.19 with a price of $246.08 and an EPS of $8.43.
Maximum annual increase: 52.25% in 2015
Maximum annual decrease: -43.33% in 2022
Year | PE ratio | Change |
---|---|---|
2023 | 44.13 | 47.59% |
2022 | 29.9 | -43.33% |
2021 | 52.76 | -12.85% |
2020 | 60.54 | 31.69% |
2019 | 45.97 | 31.31% |
2018 | 35.01 | -27.62% |
2017 | 48.37 | 11.76% |
2016 | 43.28 | -4.42% |
2015 | 45.28 | 52.25% |
2014 | 29.74 | -2.4% |
The current PE ratio of WST is above its 3 and 10-year averages, but it is under its 5-year average.
WST's PE ratio is less than its peer stock BAX, but it is above JNJ's and SYK's. West Pharmaceutical Services's current PE ratio of 47.12 is more than the average of its peers, which is 35.95.
Stock name | PE ratio | Market cap |
---|---|---|
JNJ Johnson & Johnson | 25.79 | $374.39B |
MDT Medtronic plc | 28.44 | $108.68B |
TFX Teleflex Inc | 37.68 | $8.85B |
SYK Stryker Corp | 41.37 | $148.73B |
BDX Becton Dickinson & Co | 46.48 | $65.16B |
WST West Pharmaceutical Services Inc | 47.12 | $23.24B |
BAX Baxter International Inc | 157.1 | $16.84B |
ICUI Icu Medical Inc | N/A | $4.13B |
PLL Piedmont Lithium Inc | N/A | $234.22M |
As of Nov 21, 2024, WST stock has a price to earnings ratio of 47.12.
Over the last 3 years, the average PE ratio for WST stock is 43.94.
Over the last 5 years, the average PE ratio for WST stock is 47.61.
Over the last ten years, the quarterly PE ratio reached its highest level at 64.99 in the Sep 2020 quarter.
The current PE ratio of WST is 4.6% higher than the 10-year historical average.
You can calculate the P/E ratio by dividing the most recent stock price by the trailing twelve months earnings per share(EPS). As of today (Nov 21, 2024), West Pharmaceutical Services's share price is $320.88. The company's earnings per share for the trailing twelve months (TTM) ending Sep 2024 is $6.81. Therefore, West Pharmaceutical Services's price to earnings ratio for today is 47.12. PE RATIO(47.12) = STOCK PRICE($320.88) / TTM EPS($6.81)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from and Sharadar.